Drug exsorption from blood into the gastrointestinal tract

被引:58
作者
Arimori, K [1 ]
Nakano, M [1 ]
机构
[1] Kumamoto Univ, Dept Pharm, Kumamoto 8600811, Japan
关键词
intestinal secretion; exsorption; active transport; P-glycoprotein; intestinal lumen;
D O I
10.1023/A:1011959828103
中图分类号
O6 [化学];
学科分类号
0703 [化学];
摘要
Drugs are exsorbed from the blood across the gastrointestinal membranes by passive or active processes. In the case of a passive transport mechanism, the exsorption of drugs depends on the concentration gradients between the serosal and mucosal sides. The extent of secretion (exsorption) is determined by numerous factors such as extent of binding to serum proteins, distribution volume, lipophilicity, pKa and molecular size of drugs, and the blood flow rate in the gut. Specific transport systems such as P-glycoprotein (P-gp), organic cation and organic anion transporters are found to be involved in active intestinal secretion of drugs. Intestinal secretory transport systems reduce the extent of drug absorption sometimes resulting in low oral bioavailability. It is, therefore, important to know whether poor drug absorption is due to the involvement of specialized secretory transport systems. Modulation of intestinal secretory transport can be a means to enhance absorption of drugs with low oral bioavailability if exsorption of drugs is based on active secretion pathways that are open for control from the "outside."
引用
收藏
页码:371 / 376
页数:6
相关论文
共 50 条
[1]
ARIMORI K, 1989, CHEM PHARM BULL, V37, P3148
[2]
ARIMORI K, 1989, INT J CLIN PHARM TH, V27, P280
[3]
ARIMORI K, 1988, J PHARMACOBIO-DYNAM, V11, P1
[4]
THE INTESTINAL DIALYSIS OF INTRAVENOUSLY ADMINISTERED PHENYTOIN BY ORAL ACTIVATED-CHARCOAL IN RATS [J].
ARIMORI, K ;
NAKANO, M .
JOURNAL OF PHARMACOBIO-DYNAMICS, 1987, 10 (04) :157-165
[5]
EVIDENCE FOR A POLARIZED EFFLUX SYSTEM IN CACO-2 CELLS CAPABLE OF MODULATING CYCLOSPORINE-A TRANSPORT [J].
AUGUSTIJNS, PF ;
BRADSHAW, TP ;
GAN, LSL ;
HENDREN, RW ;
THAKKER, DR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 197 (02) :360-365
[6]
Intestinal absorption barriers and transport mechanisms, including secretory transport, for a cyclic peptide, fibrinogen antagonist [J].
Aungst, BJ ;
Saitoh, H .
PHARMACEUTICAL RESEARCH, 1996, 13 (01) :114-119
[7]
Mixed-effect modeling for detection and evaluation of drug interactions: Digoxin-quinidine and digoxin-verapamil combinations [J].
Bauer, LA ;
Horn, JR ;
Pettit, H .
THERAPEUTIC DRUG MONITORING, 1996, 18 (01) :46-52
[8]
EVIDENCE FOR A POLARIZED EFFLUX SYSTEM FOR PEPTIDES IN THE APICAL MEMBRANE OF CACO-2 CELLS [J].
BURTON, PS ;
CONRADI, RA ;
HILGERS, AR ;
HO, NFH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 190 (03) :760-766
[9]
Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells [J].
Cavet, ME ;
West, M ;
Simmons, NL .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (06) :1389-1396
[10]
CYCLOSPORINE AND QUINIDINE INHIBITION OF RENAL DIGOXIN EXCRETION - EVIDENCE FOR LUMINAL SECRETION OF DIGOXIN [J].
DELANNOY, IAM ;
KOREN, G ;
KLEIN, J ;
CHARUK, J ;
SILVERMAN, M .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (04) :F613-F622